Diagnosis and treatment related gene for abdominal aortic aneurysm

An abdominal aortic aneurysm and gene technology, which is applied in the field of tumor diagnosis by detecting abnormality of FAM210B, can solve the problem that the pathogenesis of abdominal aortic aneurysm is not completely clear.

Inactive Publication Date: 2017-09-19
QINGDAO MEDINTELL BIOMEDICAL CO LTD
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the specific pathogenesis of abdominal aortic aneurysm is not completely clear. Existing reports have shown that its pathogenesis is closely related to factors such as genetic factors, inflammation, protease degradation, and smooth muscle cell apoptosis. different mutations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diagnosis and treatment related gene for abdominal aortic aneurysm
  • Diagnosis and treatment related gene for abdominal aortic aneurysm
  • Diagnosis and treatment related gene for abdominal aortic aneurysm

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Example 1 Gene Chip Screening for Differentially Expressed Genes

[0061] 1. Tissue acquisition and processing: Collect 2 live specimens of the middle layer of the AAA artery wall and 2 copies of the normal infrarenal aortic control tissue. Under sterile and RNase-free conditions, cut the aortic wall at about 4 cm below the flat renal artery. Rinse with sterilized normal saline to remove blood stains, remove arterial intima and intima from the collected tissues, and quickly (<5 min) freeze them in liquid nitrogen for later use.

[0062] 2. RNA extraction and cDNA synthesis

[0063] The aneurysm tissues preserved in liquid nitrogen were placed in a ceramic mortar under the low temperature environment of liquid nitrogen and crushed into powder, added Trizol reagent to homogenate, centrifuged, and the supernatant was extracted twice with 1:1 acidic phenol-chloroform After extraction with sodium acetate and 5:1 acidic phenol-chloroform, an equal volume of isopropanol preci...

Embodiment 2

[0072] Example 2 Verification of Differentially Expressed Genes in Large Samples

[0073] The expression selection gene chip in abdominal aortic aneurysm tissue was selected as the research target for reverse validation.

[0074] 1. Tissue acquisition and processing: According to the method in Example 1, 30 live specimens of the middle layer of the AAA artery wall and 40 normal infrarenal aortic control tissues were collected.

[0075] 2. RNA extraction

[0076] RNA extraction was carried out according to the method of Example 1.

[0077] 3. Reverse transcription

[0078] 1 μg of total RNA was reverse-transcribed to synthesize cDNA using reverse transcription buffer. Use 25μl reaction system, take 1μg total RNA for each sample as template RNA, add the following components to the PCR tube respectively: DEPC water, 5× reverse transcription buffer, 10mmol / L dNTP, 0.1mmol / l DTT, 30μmmol / l Oligo dT, 200 U / μl M-MLV, template RNA. Incubate at 42°C for 1h, then centrifuge briefly...

Embodiment 3

[0089] Example 3 overexpression of FAM210B gene expression

[0090] 1. Construction of FAM210B gene recombination plasmid

[0091] (1) amplifying the coding sequence of the FAM210B gene;

[0092] (2) Design amplification primers;

[0093] (3) The amplified FAM210B gene was connected to the expression vector pcDNA3.0 to construct the pcDNA3.0-FAM210B recombinant expression vector.

[0094] 2. Culture of human aortic smooth muscle cells

[0095] T / G HA-VSMC cells (referred to as HVSMC cells) were treated with DMEM high-glucose medium containing 10% fetal bovine serum (FBS) plus penicillin 100 units / ml and streptomycin 100 μg / ml, placed at 37°C, 5% CO 2 Cultured in an incubator, the culture medium was changed every 24 hours, and the cells were passaged once every 48 hours. Cells in the logarithmic growth phase were used for subsequent experiments.

[0096] 3. Cell transfection

[0097] Lipofectamine2000 was used as transfection reagent. The experiment was divided into two ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
cover factoraaaaaaaaaa
Login to view more

Abstract

The invention discloses application of FAM210B in the preparation of diagnostic tools for abdominal aortic aneurysm. Experiments prove that FAM210B has expression differences in normal control tissues and abdominal aortic aneurysm tissues; therefore, it is reckoned that FAM210B is a molecular marker for diagnosing abdominal aortic aneurysm. Experiments via in-vitro cultured cells prove that by accelerating the expression of FAM210B, it is possible to inhibit the apoptosis of human aortic smooth muscle cells; therefore, it is reckoned that FAM210B is a drug target for treating abdominal aortic aneurysm. As a new molecular marker for diagnosing and treating abdominal aortic aneurysm, the molecular marker has a promising clinical application prospect.

Description

technical field [0001] The invention relates to the field of tumor diagnosis and treatment, more specifically, the invention relates to a tumor diagnosis method by means of detecting FAM210B abnormality; and a tumor therapeutic agent for activating FAM210B gene or protein. Background technique [0002] Abdominal aortic aneurysm (AAA) refers to a disease characterized by localized expansion and bulging of the abdominal aorta due to lesion or loss of the abdominal aortic wall, with a pulsating mass as the main symptom. AAA is usually defined as the continuous expansion of the three-layer structure of the abdominal aortic arterial wall to more than 1.5 times the diameter of the abdominal aorta at the renal artery. It is a common arterial degenerative disease with a high mortality rate. At present, the specific pathogenesis of abdominal aortic aneurysm is not completely clear. Existing reports have shown that its pathogenesis is closely related to factors such as genetic factors...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68G01N33/574A61K45/00A61P35/00
CPCA61K45/00C12Q1/6886C12Q2600/158G01N33/57407
Inventor 李曙光孙锦云
Owner QINGDAO MEDINTELL BIOMEDICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap